Suneel Mohammed, Dorwyn W. Croom
Abstract
Open-access reader
To the Editor: Celecoxib (Celebrex), a cyclooxygenase (COX)-2–specific nonsteroidal antiinflammatory drug (NSAID), was recently introduced in the U.S. market. COX-2 is induced in inflammation, wher...
OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To the Editor: Celecoxib (Celebrex), a cyclooxygenase (COX)-2–specific nonsteroidal antiinflammatory drug (NSAID), was recently introduced in the U.S. market. COX-2 is induced in inflammation, wher...
Key concepts: Celecoxib, Cyclooxygenase, Medicine, Nonsteroidal, Antiinflammatory drug, Prostaglandin-Endoperoxide Synthase, Pharmacology, Inflammation